6525--Envision Technologies 3D Bioplotter (or equal)

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

The solicitation number 36C24E22Q0233 is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2022-07.

This requirement will be awarded using a cascading set-aside under the associated NAICS code 339112 Surgical and Medical Instrument Manufacturing with a small business size standard of 1000 employees.

The full solicitation document is included as an attachment to this notice; to include: a list of contract line items, a Description of requirements for the items to be acquired, SOW/PWS, Date(s) and place(s) of delivery, and applicable clauses and provisions.

Evaluation procedures: Evaluation of offers will be made in accordance with FAR 13.106-2, and award made on the basis of lowest price technically acceptable. All response shall demonstrate meeting/exceeding the salient physical, functional, or performance characteristics specified in this solicitation.

The salient characteristics for the 3D-Bioplotting System are based on the following specs and additional modules:

high resolution (position precision) placement of materials

camera-assisted material calibration and photographic record log for Z-axis (height) calibration precision and recording

broad range high and low temperature printing capabilities

multiple printing heads that are interchangeable

UV curing capabilities

inkjet capabilities

capability for sterile preparation of sterile printer materials

capability for high-capacity loading of drug and test materials

Computer Aided Design (CAD) software and upgrades for high precision printing design parameters

The 3D-Bioplotter extrusion application is commonly used and allows the refinement of specific applications. For successful transplantation, material matrices might have to be individually optimized to enhance the survival of different cell types and/or release of drugs. The 3D-Bioplotter is not restricted to proprietary reagents; printing materials can be customized, especially important for skeletal tissues that are composed of diverse hard and soft tissues with processes mediated by different matrices and cells. In particular, the flexibility in the choice materials might be critical for prospective clinical applications, which require FDA-approved materials.

The 3D-Bioprinting system characteristics are based on the Envision Technologies (EnvisionTec) 3D-Biplotter system and is solicited as a Brand Name or Equal per FAR 52.211-6.

This is a BRAND NAME OR EQUAL REQUIREMENT for the EnvisionTec Manufacturer Series 3D-Biplotter system and attachments. Any equivalent products shall meet/exceed all of the salient characteristics of the system above and stated elsewhere in the solicitation. All responses shall include product information that demonstrate as a minimum, equivalency to the salient characteristics.

Delivery FOB Destination to:

VA Loma Linda Medical Center

11201 Benton St

Loma Linda, CA 92357

The following provisions and clauses apply to this acquisition:

52.212-1, Instructions to Offerors Commercial, (ix) A statement regarding the applicability of

Offerors are advised to include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with its offer.

52.212-4, Contract Terms and Conditions Commercial Items,

52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders Commercial Items,

52.211-6, Brand Name or Equal

852.211-73, Brand name or equal.

852.246-70, Guarantee

Additional contract requirement(s) or terms and conditions determined by the contracting officer:

Set Aside Cascading set-aside procedures.

Any award resulting from this solicitation will be made using a cascading set-aside order of precedence as follows:

1. In accordance with FAR Subpart 19.1405 and VAAR Subpart 819.7005, any award under this solicitation will be made on a competitive basis first to an eligible Service Disabled Veteran Owned small business [SDVOSB] concern provided that the conditions of 38 U.S.C. 8127(d) are met (the VA Rule of Two) whereby the Contracting Officer receives adequate competition of two or more small business concerns owned and controlled by Veterans, and that the award can be made at a fair and reasonable price that offers the best value to the United States.

2. If there is inadequate competition for award to an SDVOSB concern, the SDVOSB set-aside shall be withdrawn and cascaded to the next contracting order of priority in accordance with VAAR 819.7004, which is Veteran Owned Small Businesses (VOSB) and conducted in accordance with the procedures set forth in VAAR 819.7006 provided that the conditions of 38 U.S.C. 8127(d) are met (the VA Rule of Two) whereby the Contracting Officer receives adequate competition of two or more small business concerns owned and controlled by Veterans, and that the award can be made at a fair and reasonable price that offers the best value to the United States.

3. If there continues to be inadequate competition between SDVOSB and VOSB concerns, the cascading will continue through the contracting order of priority in accordance with VAAR 819.7004 and FAR 19.203. If the contracting officer determines that offers from small business concerns do not meet the solicitation requirements in terms of technical acceptability, past performance, and fair market price, the small business set-aside[s] will be withdrawn and award will be made on the basis of full and open competition.

Adequate competition:

Adequate competition shall be deemed to exist if At least two competitive offers are received from qualified, responsible business concerns at the set-aside tier under consideration; and Award could be made at fair market price as determined in accordance with FAR 19.202-6.

The VA contracting officer reserves the right to consider competitive proposals submitted from all responsible offerors (including large businesses) in determining the fair market price.

Due date and submission of quotes:

The quotes are due on 9/19/2022 at 10:00 AM EST and shall be directed solely electronically to Michael.haydo@va.gov. Quotes shall be marked with the solicitation number.

Responses to the RFQ shall include all information in a single document with only equipment specifications as a separate attachment.

Response on company letterhead is not required, but the response documentation shall contain as a minimum the solicitation number, company name, address, phone number, Point of Contact information, Unique Entity ID (found at SAM.gov), company business size, and estimated delivery date.

Responses not complying with the above specifications and formatting will be determined to be non-responsive and will not be accepted.

Information regarding the solicitation may be addressed to the Contracting Officer, Michael Haydo, michael.haydo@va.gov